Vitamin D nutrient to treat TB begs the prevention question.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Efficacy of vitamin DTrials · 2017
   Trial
2. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.PloS one · 2013
   Trial
3. The Potential Role of Vitamin D in the Development of Tuberculosis in Chinese Han Population: One Case-Control Study.Frontiers in medicine · 2022
   Article
4. Efficacy and Safety of Vitamin D Supplementation for Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.Iranian journal of public health · 2018
   Review
5. Vitamin D and activated vitamin D in tuberculosis in equatorial Malaysia: a prospective clinical study.BMC infectious diseases · 2017
   Observational
6. Vitamin D Status in South Africa and Tuberculosis.Lung · 2015
   Review
7. Vitamin D in early childhood and the effect on immunity to Mycobacterium tuberculosis.Clinical & developmental immunology · 2012
   Review
8. Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study.BMC infectious diseases · 2011
   Article
9. A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis.Journal of research in pharmacy practice
   Review

Corrections and comments

• Comment on
  High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as